Agilent Technologies Inc.

WKN 929138 ISIN US00846U1016

Quote/Chart

  • Bid

    -

    0 Units

  • Ask

    -

    0 Units

  • Change compared with previous day (price)

    -0.72 / -0.56 %

  • Spread (Act/ Rel)

    - / -

  • Today's high (Price)

    126.9

  • Today's low (Price)

    126.9

Facts & figures

Price data

Trade platform Börse Stuttgart (XSTU)  
Last price 126.9 G 0 Units
Price determination time 04/26/2024 / 08:13:23 AM
Daily volume (units) 0
Daily high / low 126.9 126.9
Prev. day's price 127.62 (25.04.)
Change day before -0.72 -0.56 %
52 week high / low 137.4 (08/03) 92.52 (30/10)

Key Figures (in EUR)

2023 2022 2021
Earnings per share 3.90 3.92 3.30
Dividends per share 0.84 0.79 0.65
Dividend Yield in % 0.87% 0.61% 0.49%
Dividend growth in % - -6.13% -17.43%
Price - Earnings ratio 24.68 33.10 39.96
Price - Book ratio 5.17 7.70 8.83
Price - Sales ratio 4.48 6.06 7.65
Price - Cash Flow Ratio 17.27 31.63 32.56

Master Data

WKN
929138
ISIN
US00846U1016
Symbol
AG8
Exchange segment
Open Market
Type of financial instrument
Equity
Denomination
Agilent
Index membership
-
Trading segment
-
Trading hours
08:00:00 - 22:00:00
Trading currency
Euro
Nominal currency
US Dollar
Settlement currency
Euro
Sector and industry
Technology, Electrotechnology
Number of shares
293.06 Mil.
Market capitalisation
37.19 Bil.

Performance overview

1W 1M 3M 6M 1Y 3Y 5Y YTD
Performance 2.29% -5.12% 4.53% 28.57% 7.22% 12.40% 83.99% 1.16%
High 129.72 135.60 137.40 137.40 137.40 151.55 151.55 137.40
Low 124.38 123.36 120.05 92.52 92.52 92.52 55.76 116.40

Company profile

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.